查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956255

日本泛自闭症障碍市场规模、份额、趋势和预测：按自闭症类型、治疗方法和地区划分，2026-2034年

Japan Autism Spectrum Disorder Market Size, Share, Trends and Forecast by Autism Type, Treatment, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本泛自闭症障碍）市场规模达1.0982亿美元。预计到2034年，该市场规模将达到2.8782亿美元，2026年至2034年的复合年增长率（CAGR）为11.30% 。成长要素包括：政府主导的医疗改革扩大了儿童和青少年获得心理健康服务的管道；数位医疗和远端医疗服务模式；以及由于检测准确率的提高， 泛自闭症障碍患病率上升，从而推高了治疗需求。此外，对早期疗育计画和专业治疗机构的日益重视也促进了日本泛自闭症障碍市场份额的扩大。

日本泛自闭症障碍市场趋势：

透过政府主导的保险改革扩大精神科医疗服务的覆盖范围。

日本政府透过厚生劳动省实施了旨在改善神经发育障碍儿童和青少年心理健康服务的全面保险改革。这些政策显着改善了全国泛自闭症障碍的治疗状况。这项始于2014年的保险改革透过提供经济奖励，扩大了青少年门诊精神科服务。这解决了专业心理健康人员严重短缺的问题，并减轻了寻求治疗的家庭的经济负担。政府在意识到多家医疗机构的候诊名单超过300人，且发育障碍患者通常需要等待三个月以上才能获得初次咨询后，立即采取了相应的政策措施。这些措施的显着成效体现在全国门诊心理治疗的保险理赔数量几乎翻了一番，从2015年的每万名儿童521例增至2022年的1034.5例。不过，各地的实施情况存在差异。根据2024年《儿童青少年精神科专业短缺指数》，德岛县註册儿童青少年精神科医生的数量和专科医疗机构数量均显着增加，这表明资源配置方面取得的进展远超医疗费用数据所显示的水平。透过结合国家财政奖励措施和为18岁以下儿童提供免费医疗服务的市级项目，在不增加家庭经济负担的情况下扩大服务范围成为可能，从而显着提高了日本各年龄层和各地区的医疗服务利用率。

数位医疗和远端医疗的加速普及正在改变医疗服务的提供方式。

在日本，数位健康科技和远端医疗平台正经历前所未有的成长，从根本上改变了泛自闭症障碍的治疗方式以及全国各地的精神健康服务提供方式。人口快速老化和医疗资源获取方面的区域差异，推动了创新数位解决方案的普及，这些方案能够实现远距医疗和持续的病患监测。自2014年修订《药事法》以来，日本政府积极支持这项转型，推行前瞻性的政策和措施，并启动了许多计划，以支持远端医疗平台、电子健康记录（EHR）和其他数位健康工具的发展。 CureApp是日本先驱企业，它为更多数位健康解决方案的出现铺平了道路。据估计，日本远端医疗产业在2024年市场规模将达到14亿美元，并有望以20.3%的复合年增长率成长，到2033年达到72亿美元。这一成长主要得益于日本政府在新冠疫情期间放宽了远距远端医疗监管，这使得人们重新认识到远端医疗服务的价值，并加速了全球数位医疗解决方案的普及。高度发展的数位基础设施，包括广泛的互联网接入和先进的行动网络，以及政府的大力支持和消费者对数位化医疗解决方案日益增长的信心，共同为远端医疗市场的扩张创造了非常有利的环境。人工智慧（AI）和数据分析正远端医疗平台中，以提高诊断准确性、个人化治疗方案并简化行政流程。机器学习演算法正在分析医疗数据，以预测患者的治疗结果并识别泛自闭症障碍患者的潜在健康风险。

泛自闭症障碍盛行率上升和检测准确率提高

日本泛自闭症障碍）市场的成长主要受泛自闭症障碍及相关神经发育障碍在各年龄层中盛行率和检出率显着上升的推动。一项利用国民健康保险医疗费用资料库进行的全国性综合调查证实， 泛自闭症障碍的诊断率和盛行率均显着上升，反映出医疗专业人员、相关人员和公众对该疾病的认知度不断提高。 2024年，日本18岁以下族群的自杀死亡人数达到创纪录的524人，凸显了泛自闭症障碍症（ADHD）相关的严重公共卫生问题。这些疾病的诊断需要及时进行精神科干预，且在全国范围内呈快速增长趋势。 0至19岁青少年接受认知行为疗法的索赔数量从2014年的691例（占所有心理治疗索赔的1.5%）大幅增长至2022年的4497例（占12.8%），所有年龄段的儿童均呈现出显着的增长趋势。诊断能力的提升、透过在婴儿3-5个月、18个月和36个月龄时进行定期健康检查（参与率超过95%）而实施的系统性筛检计划，以及专门发育诊所的建立，都促进了自闭症频谱病例的早期准确识别。教育机构的认知水平和筛检能力也得到了提高，《学校教育法》现已将泛自闭症障碍认定为一种独立的残疾类别。因此，现在可以透过特殊教育、特殊教育班级和资源教室等途径获得适当的支持。据估计，全国约有159,000名自闭症儿童在各种环境中接受教育支持。

本报告解答的主要问题

  • 日本泛自闭症障碍市场目前发展状况如何？预计未来几年将如何发展？
  • 日本泛自闭症障碍市场依自闭症类型分類的细分如何？
  • 日本泛自闭症障碍市场依治疗方法分類的组成是怎样的？
  • 日本泛自闭症障碍市场的区域分布如何？
  • 日本泛自闭症障碍市场价值链的不同阶段有哪些？
  • 日本泛自闭症障碍市场的主要驱动因素和挑战是什么？
  • 日本泛自闭症障碍市场的结构是怎么样的？主要企业有哪些？
  • 日本泛自闭症障碍市场竞争有多激烈？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本泛自闭症障碍市场：引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本泛自闭症障碍市场：现状

  • 过去与现在的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本泛自闭症障碍市场：依自闭症谱系障碍类型细分

  • 自闭症谱系障碍
  • 亚斯伯格症候群
  • 广泛性发展障碍
  • 儿童崩坏障碍

第七章：日本泛自闭症障碍市场：依治疗方法细分

  • 行为疗法
  • 早期疗育
  • 药物治疗
  • 饮食疗法
  • 其他的

第八章：日本泛自闭症障碍市场：区域细分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第九章：日本泛自闭症障碍市场：竞争格局

  • 概述
  • 市场结构
  • 市场定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十章：主要企业概况

第十一章：日本泛自闭症障碍市场：产业分析

  • 促进因素、抑制因素和机会
  • 波特五力分析
  • 价值链分析

第十二章附录

简介目录
Product Code: SR112026A43953

The Japan autism spectrum disorder market size reached USD 109.82 Million in 2025 . The market is projected to reach USD 287.82 Million by 2034 , exhibiting a growth rate (CAGR) of 11.30% during 2026-2034 . The market is driven by government-led insurance changes that increase children's and teenagers' access to mental health services, accelerated digital health and telemedicine adoption transforming healthcare delivery, and rising prevalence with improved detection of autism spectrum disorder driving treatment demand. Additionally, the growing focus on early intervention programs and specialized treatment centers is expanding the Japan autism spectrum disorder market share.

JAPAN AUTISM SPECTRUM DISORDER MARKET TRENDS:

Government-Led Insurance Reforms Expanding Access to Psychiatric Services

The Japanese government has implemented comprehensive insurance reforms through the Ministry of Health, Labour, and Welfare aimed at improving mental health services for children and adolescents with neurodevelopmental disorders. These policy initiatives have dramatically transformed the accessibility landscape for autism spectrum disorder treatment across the nation. The insurance reforms offered financial incentives starting in 2014 to increase outpatient psychiatric care explicitly targeting young populations, addressing the acute shortage of specialist mental health practitioners and lessening the financial burden on families seeking treatment. The government took immediate policy action after realizing that several institutions had waitlists of more than three hundred people and that first consultations for developmental disorders often took longer than three months. The significant impact of these policy measures is demonstrated by the nearly twofold increase in outpatient psychotherapy claims nationwide from 521.0 per 10,000 kids in fiscal year 2015 to 1034.5 in fiscal year 2022. Regional differences in implementation have surfaced. According to the 2024 Japan Child Mental Health Professional Shortage Areas index, Tokushima Prefecture has significantly increased the number of board-certified specialists and specialized facilities in its child and adolescent psychiatry workforce, indicating actual improvements in resource availability beyond billing data. Combining national financial incentives with municipal programs that provide free medical care for children under the age of eighteen has made it possible to expand services without placing further financial strain on families, which has greatly increased service utilization across all age groups and geographical areas of Japan.

Accelerated Digital Health and Telemedicine Adoption Transforming Healthcare Delivery

Japan is experiencing unprecedented growth in digital health technologies and telemedicine platforms, fundamentally reshaping how autism spectrum disorder treatment and mental health services are delivered throughout the country. The rapid aging population, combined with geographical disparities in healthcare access, has catalyzed the adoption of innovative digital solutions that enable remote consultations and continuous patient monitoring. Since amending the Pharmaceutical Act in 2014, the Japanese government has actively supported this transition by putting forward-thinking policies and initiatives into place and initiating a number of projects to assist telemedicine platforms, electronic health records, and other digital health tools. After receiving Japan's first regulatory approval in 2020, CureApp, a trailblazing firm in digital therapeutics, opened the door for more digital health solutions. The telehealth industry in Japan was estimated to be worth USD 1.4 billion in 2024 and is expected to increase at a compound yearly growth rate of 20.3 percent to reach USD 7.2 billion by 2033. The government's relaxation of telemedicine laws during the COVID-19 pandemic, which emphasized the value of remote healthcare services and sped up the adoption of digital health solutions worldwide, is what is driving this expansion. The country's highly developed digital infrastructure, characterized by widespread internet penetration and sophisticated mobile networks, combined with strong government support and increasing consumer trust in digital health solutions, creates an exceptionally favorable environment for telemedicine market expansion. Artificial intelligence and data analytics are being increasingly integrated into telehealth platforms to enhance diagnostic accuracy, personalize treatment plans, and streamline administrative tasks, with machine learning algorithms analyzing medical data to predict patient outcomes and identify potential health risks for individuals with autism spectrum disorder.

Rising Prevalence and Improved Detection of Autism Spectrum Disorder

The Japan Autism Spectrum Disorder market growth is propelled by the increasing prevalence and substantially improved detection rates of autism spectrum disorder and related neurodevelopmental conditions across all age groups. Japan has witnessed marked increases in both the incidence and prevalence of autism spectrum disorder diagnoses, confirmed by comprehensive nationwide studies utilizing the National Database of Health Insurance Claims, reflecting heightened awareness among healthcare professionals, educators, and the general public. With 524 suicide deaths among individuals under the age of eighteen in fiscal year 2024, the highest number ever recorded in Japan and highlighting the serious public health issue of autism spectrum disorder and attention-deficit hyperactivity disorder diagnoses that require prompt psychiatric intervention have been sharply rising throughout the nation. Cognitive behavioral therapy claims for Japanese youth aged zero to nineteen years increased markedly from 691 cases representing 1.5 percent of all psychotherapy claims in fiscal year 2014 to 4,497 cases representing 12.8 percent in fiscal year 2022, with significant upward trends observed across all pediatric age groups. The expansion of diagnostic capabilities, implementation of systematic screening programs through regular infant health checkups at three to five months, eighteen months, and thirty-six months with participation rates exceeding ninety-five percent, and the development of specialized developmental clinics have collectively contributed to earlier and more accurate identification of autism spectrum disorder cases. Educational institutions have enhanced their awareness and screening capabilities, with the School Education Act recognizing autism spectrum disorder as a discrete category of disability, enabling children to receive appropriate support through schools for special needs education, specialized classes, and resource rooms, with estimates indicating approximately 159,000 children with autism receiving educational support across various settings nationwide.

JAPAN AUTISM SPECTRUM DISORDER MARKET SEGMENTATION:

Autism Type Insights:

  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Childhood Disintegrative Disorder

Treatment Insights:

  • Behavioral Approach
  • Early Intervention
  • Medication
  • Dietary Approach
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the Japan autism spectrum disorder market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan autism spectrum disorder market on the basis of autism type?
  • What is the breakup of the Japan autism spectrum disorder market on the basis of treatment?
  • What is the breakup of the Japan autism spectrum disorder market on the basis of region?
  • What are the various stages in the value chain of the Japan autism spectrum disorder market?
  • What are the key driving factors and challenges in the Japan autism spectrum disorder market?
  • What is the structure of the Japan autism spectrum disorder market and who are the key players?
  • What is the degree of competition in the Japan autism spectrum disorder market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Autism Spectrum Disorder Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Autism Spectrum Disorder Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Autism Spectrum Disorder Market - Breakup by Autism Type

  • 6.1 Autistic Disorder
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Asperger Syndrome
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Pervasive Developmental Disorder
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Childhood Disintegrative Disorder
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)

7 Japan Autism Spectrum Disorder Market - Breakup by Treatment

  • 7.1 Behavioral Approach
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Early Intervention
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Medication
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Dietary Approach
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2020-2025)
    • 7.5.2 Market Forecast (2026-2034)

8 Japan Autism Spectrum Disorder Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Autism Type
    • 8.1.4 Market Breakup by Treatment
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Autism Type
    • 8.2.4 Market Breakup by Treatment
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Autism Type
    • 8.3.4 Market Breakup by Treatment
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Autism Type
    • 8.4.4 Market Breakup by Treatment
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Autism Type
    • 8.5.4 Market Breakup by Treatment
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Autism Type
    • 8.6.4 Market Breakup by Treatment
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Autism Type
    • 8.7.4 Market Breakup by Treatment
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Autism Type
    • 8.8.4 Market Breakup by Treatment
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Autism Spectrum Disorder Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Autism Spectrum Disorder Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix